FDA-Approved Sickle Cell Treatment for Children Five Years and Older
Yutaka Niihara, CEO of Emmaus Life Sciences, discusses Sickle Cell Disease in underserved minority populations and his passion for finding a treatment.
270 articles
Yutaka Niihara, CEO of Emmaus Life Sciences, discusses Sickle Cell Disease in underserved minority populations and his passion for finding a treatment.
Eric Snyder from Geneticure discusses their recently presented data on a study utilizing their algorithm which can predict which hypertension drug would...
Pamela Jones, MD, from Massachusetts General Hospital and a presenter at the 2019 American Association of Neurological Surgeons (AANS) Scientific Meetin...
In this health supplier segment, pediatric emergency physician and pain specialist, Dr. Learn more on Health Professional Radio.
David Arthur, CEO of Salarius Pharmaceuticals, discusses the enrollment in a Phase 1 trial for their lead program which is for the treatment of Ewing Sa...
CJ Barnum, Ph.D., Director of Neuroscience for INmune Bio discusses the award of a $1 million dollar grant from the Alzheimer's Association to begin a c...
Feldman MD, Medical Director of Clearview Eye & Laser Medical Center in San Diego and one of the nation’s top LASIK specialists, discusses SMILE (smal...
Corey Hunter, MD, an interventional pain specialist and founder of The Ainsworth Institute of Pain Management and assistant clinical professor at Mount ...
Harold Minkowitz discusses a potential breakthrough in non-opioid post-surgery pain management called HTX-011. Learn more on Health Professional Radio.
Carol Satler discusses the recent (Nov 2018) FDA approval of Gamifant® (emapalumab-lzsg), the first and only treatment indicated for primary hemophagoc...